NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 1 - 30 of 30 results found.

Activity Company Description Location
Company Adrenas Therapeutics Inc. Activity: Research and Development Research and Development Company Description Adrenas Therapeutics, a Bridge Bio subsidiary, is developing a gene therapy for the treatment of a monogenic disease that presents in childhood. Location Raleigh
Company Aruna Bio Activity: Research and Development Research and Development Company Description Aruna Bio develops neural exosomes for the treatment of neurodegenerative diseases. The company is utilizing its proprietary neural exosome platform and manufacturing capability to develop a pipeline of therapeutics. Location Raleigh
Company Atsena Therapeutics Inc. Activity: Research and Development Research and Development Company Description Atsena Therapeutics is developing ocular gene therapies to reverse or prevent blindness. Location Durham
Company Beam Therapeutics Activity: Production and Manufacturing Production and Manufacturing Company Description Beam Therapeutics will manufacture precision genetic medicines through the use of base editing technology at its RTP site. Location Durham
Company Bedrock Therapeutics Inc. Activity: Research and Development Research and Development Company Description Bedrock Therapeutics is an AAV research and development company developing platform technologies and therapeutics. Location Raleigh
Company Black Swan Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. Location Wake Forest
Company CasTag Biosciences Inc. Activity: Production and Manufacturing Production and Manufacturing Company Description CasTag Biosciences provides custom AAV kits. It uses CRISPR-knock in technology to produce genome-wide arrayed libraries with a variety of donors for endogenous protein analysis in cells and tissue. Location Durham
Company Cellective BioTherapy Inc. Activity: Research and Development Research and Development Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. Location Research Triangle Park
Company CLAIRIgen Activity: Research and Development Research and Development Company Description CLAIRIgen develops viral vector platforms for gene therapy products to treat central nervous system diseases and conditions. Location Durham
Company Couragen Biopharmaceutics LLC Activity: Research and Development Research and Development Company Description Couragen Biopharmaceutics develops gene and protein therapy products for preclinical and clinical use for the treatment of genetic and chronic diseases. Couragen also provides custom adeno-associated virus vectors as a tool for laboratory research. Location Chapel Hill
Company Denizen Biologics LLC Activity: Research and Development Research and Development Company Description Denizen Biologics develops gene therapy vectors to enhance the capability of genetic medicine and improve the outcomes for patients. Location Cary
Company Enzerna Biosciences Inc. Activity: Research and Development Research and Development Company Description Enzerna Biosciences is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term curative gene therapies for rare genetic disorders such as Huntington's Disease and Myotonic Dystrophy. Location Chapel Hill
Company Enzyvant Inc. Activity: Research and Development Research and Development Company Description Enzyvant develops therapeutics for treatment of rare diseases. Their focuses are RVT-802, an investigational tissue-based therapy for immune deficiency resulting from DiGeorge Anomaly, and RVT-801, an enzyme replacement therapy to treat Farber disease. Location Durham
Company Epigenos Biosciences Inc. Activity: Research and Development Research and Development Company Description Epigenos Biosciences develops personalized epigenome-based therapeutics that leverage Cas9 technology to treat disease at the root of gene mis-regulation. Location Chapel Hill
Company Falcon Therapeutics Inc. Activity: Research and Development Research and Development Company Description Falcon Therapeutics develops genetically distinct cell therapy to treat solid tumors by turning a patient's own skin cells into "Trilogy Cells" that seek out and destroy cancer cells. Location Durham
Company FastBack Bio LLC Activity: Research and Development Research and Development Company Description FastBack Bio is developing CAR-T therapy for treatment of solid tumors. Location Raleigh
Company General Biosystems Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description General Biosystems provides gene synthesis, molecular biology, and protein expression and purification services. Location Durham
Company GeneVentiv Therapeutics Inc. Activity: Research and Development Research and Development Company Description GeneVentiv Therapeutics is a gene therapy company developing a cure for Hemophilia A, Hemophilia B or Factor VIII deficiency, with or without inhibitors. Location Raleigh
Company GENEWIZ Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description Genewiz provides custom DNA sequencing, gene synthesis, genomics, next-generation sequencing and molecular biology in a GLP/cGMP regulatory environment. Location Research Triangle Park
Company Inceptor Bio LLC Activity: Research and Development Research and Development Company Description Inceptor Bio develops next-generation cell therapy platforms, across multiple cell types, to cure cancers. Its site includes a manufacturing facility for production of its therapies. Location Raleigh
Company Isolere Bio Inc. Activity: Research and Development Research and Development Company Description Isolere Bio is developing novel, non-chromatographic technologies for the purification of biologics such as antibodies, gene delivery vectors and personalized cell therapies. Location Durham
Company Jaguar Gene Therapy LLC Activity: Research and Development Research and Development Company Description Jaguar Gene Therapy develops gene therapies for patients suffering from severe genetic diseases. Location Cary
Company Kitty Hawk Biosciences Inc. Activity: Research and Development Research and Development Company Description Kitty Hawk Biosciences is developing enabling technologies for difficult-to-transfect cells to reduce the cost and complexity of ex-vivo cell manipulations for applications in research and clinical settings. Location Cary
Company Kriya Therapeutics Inc. Activity: Production and Manufacturing Production and Manufacturing Company Description Kriya Therapeutics develops AAV-based gene therapies for the treatment of type 1 and type 2 diabetes, severe obesity, and other indications. This location is the company's internal manufacturing facility. Location Morrisville
Company NeuroGT Inc. Activity: Research and Development Research and Development Company Description NeuroGT is developing gene therapy products to treat rare neurogenetic diseases. Location Durham
Company OncoTrap Inc. Activity: Research and Development Research and Development Company Description OncoTrap is developing a nucleic acid delivery platform for accommodating nucleic acid-based therapeutics, designed to deliver therapeutic genes to tumor sites. Location Research Triangle Park
Company PhosphoGam Inc. Activity: Research and Development Research and Development Company Description PhosphoGam is developing allogeneic cell immunotherapies using gamma/delta T-cells to treat a variety of cancers. Location Durham
Company RainBio Inc. Activity: Research and Development Research and Development Company Description RainBio is developing AAV (adeno-associated virus) gene therapy corneal treatments to address the unmet need of treatment of rare corneal blinding diseases. Location Raleigh
Company Sio Gene Therapies Activity: Research and Development Research and Development Company Description Sio Gene Therapies develops gene therapies to treat neurologic conditions. Location Durham
Company ViraSource LLC Activity: Contract Research and Testing Contract Research and Testing Company Description ViraSource propagates and purifies BSL-1, BSL-2 viruses and bacteriophages. ViraSource also provides virus modifications and animal models of viral infections and antiviral immune responses. Location Durham